Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization.
Francica JR, Sheng Z, Zhang Z, Nishimura Y, Shingai M, Ramesh A, Keele BF, Schmidt SD, Flynn BJ, Darko S, Lynch RM, Yamamoto T, Matus-Nicodemos R, Wolinsky D; NISC Comparative Sequencing Program; Nason M, Valiante NM, Malyala P, De Gregorio E, Barnett SW, Singh M, O'Hagan DT, Koup RA, Mascola JR, Martin MA, Kepler TB, Douek DC, Shapiro L, Seder RA. Francica JR, et al. Among authors: martin ma. Nat Commun. 2015 Apr 10;6:6565. doi: 10.1038/ncomms7565. Nat Commun. 2015. PMID: 25858157 Free PMC article.
Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.
Cho MW, Kim YB, Lee MK, Gupta KC, Ross W, Plishka R, Buckler-White A, Igarashi T, Theodore T, Byrum R, Kemp C, Montefiori DC, Martin MA. Cho MW, et al. Among authors: martin ma. J Virol. 2001 Mar;75(5):2224-34. doi: 10.1128/JVI.75.5.2224-2234.2001. J Virol. 2001. PMID: 11160726 Free PMC article.
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies.
Nishimura Y, Igarashi T, Haigwood N, Sadjadpour R, Plishka RJ, Buckler-White A, Shibata R, Martin MA. Nishimura Y, et al. Among authors: martin ma. J Virol. 2002 Mar;76(5):2123-30. doi: 10.1128/jvi.76.5.2123-2130.2002. J Virol. 2002. PMID: 11836389 Free PMC article.
Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.
Imamichi H, Igarashi T, Imamichi T, Donau OK, Endo Y, Nishimura Y, Willey RL, Suffredini AF, Lane HC, Martin MA. Imamichi H, et al. Among authors: martin ma. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13813-8. doi: 10.1073/pnas.212511599. Epub 2002 Oct 7. Proc Natl Acad Sci U S A. 2002. PMID: 12370415 Free PMC article.
Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles.
Willey RL, Byrum R, Piatak M, Kim YB, Cho MW, Rossio JL Jr, Bess J Jr, Igarashi T, Endo Y, Arthur LO, Lifson JD, Martin MA. Willey RL, et al. Among authors: martin ma. J Virol. 2003 Jan;77(2):1163-74. doi: 10.1128/jvi.77.2.1163-1174.2003. J Virol. 2003. PMID: 12502833 Free PMC article.
Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.
Igarashi T, Endo Y, Nishimura Y, Buckler C, Sadjadpour R, Donau OK, Dumaurier MJ, Plishka RJ, Buckler-White A, Martin MA. Igarashi T, et al. Among authors: martin ma. J Virol. 2003 Oct;77(20):10829-40. doi: 10.1128/jvi.77.20.10829-10840.2003. J Virol. 2003. PMID: 14512533 Free PMC article.
1,145 results